fluorobenzenes has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HS; Kim, IS; Kim, Y; Lee, JJ; Myung, CS; Park, JS; Shin, CY; Yi, I; Zhang, WY | 1 |
| Buikema, H; de Smet, BJ; Groenewegen, HC; Roks, AJ; van der Harst, P; van Gilst, WH; Zijlstra, F | 1 |
2 other study(ies) available for fluorobenzenes and Hyperplasia
| Article | Year |
|---|---|
Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.
Topics: Animals; DNA; Dose-Response Relationship, Drug; Drug Synergism; Femoral Artery; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Losartan; Male; Mice; Mice, Inbred C57BL; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tunica Intima | 2010 |
Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
Topics: Angiotensin II; Animals; Fluorobenzenes; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Male; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Stents; Sulfonamides; Tunica Intima | 2008 |